Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
基本信息
- 批准号:10327440
- 负责人:
- 金额:$ 48.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAcuteAddressAstrocytesAttentionBiologyBlood - brain barrier anatomyBrainCellsCerebrovascular DisordersChronicCouplingDNADataDendritic CellsDevelopmentEndothelial CellsFunctional disorderFutureGap JunctionsGene Expression ProfileGoalsGrowthHIVHIV InfectionsHIV encephalitisHIV-1HomeostasisHumanImmune systemImmunohistochemistryImpairmentIn Situ HybridizationIn VitroIndividualInfectionInflammationKnowledgeLatent virus infection phaseLeadLife Cycle StagesMetabolicMethodsMicrogliaMyelogenousMyeloid CellsNamesNational NeuroAids Tissue ConsortiumNeurocognitiveNeurologicPathogenesisPathologyPatientsPericytesPharmacologyPopulationProvirusesPublishingRNARecording of previous eventsReporterResearchRoleSamplingSignal TransductionStructureViralViral reservoirVirusVirus ReplicationWorkbasecell typecerebrovascularcohortcomorbiditydesignexperimental studyfunctional outcomeshigh riskimmune activationin situ imagingin vivoinnovationlatent infectionmacrophagemonocytenervous system disorderneuroAIDSneuropathologyneurovascularneurovascular unitnovelprogenitorreceptorsensortranscriptometransmission process
项目摘要
ABSTRACT
HIV-1-infected individuals are at a higher risk for non-AIDS related co-morbidities, including cerebrovascular
and neurological diseases. These pathologies may be driven, at least in part, by low levels of viral replication
that persist in HIV-infected brains, which can lead to immune activation, chronic inflammation, and viral
reactivation. Experiments on microglia, astrocytes, and brain pericytes indicate that these cells are all capable,
to different degrees, to harbor HIV infection. We have pioneered research on HIV-1 infection in brain pericytes,
and indicated that these cells possess the receptor profile enabling HIV-1 infection. Recent evidence on
pericyte ontogeny identified that a substantial subpopulation of brain pericytes originates from myeloid
progenitors. We recently demonstrated HIV-1-infected pericytes in human brains with HIV encephalitis.
Furthermore, our new and exciting preliminary data suggest that brain pericytes may be capable of latent
infection and reactivation, similar to other myeloid cells. Based on these observations, we hypothesize that
brain pericytes are a key, albeit previously unrecognized, cell type for the formation of HIV-1
reservoirs in the CNS. The overarching goal of the current proposal is to characterize the latent HIV-
1 infection in brain pericytes as the necessary step for successful eradication of CNS reservoirs and
HIV cure. Consistent with this goal, Specific Aims will evaluate the formation of latent HIV infection in brain
pericytes both in vivo and in vitro. In a cohort of human brain samples with a history of achieved viral
suppression obtained from the National NeuroAIDS Tissue Consortium (NNTC), we will determine whether
brain pericytes harbor latent HIV-1 infections in HIV-suppressed patients (Aim 1). In addition, we will evaluate
transcriptional signatures of latently HIV-1-infected human primary brain pericytes (Aim 2), and delineate
functional outcomes associated with HIV infection of brain pericytes (Aim 3).
The focus on the role of pericytes in the development of viral brain HIV reservoirs is an innovative and cutting-
edge conceptual approach, consistent with the current RFA. Focusing on pericytes as a novel myeloid cell
population in the context of HIV-1 infection and brain reservoirs has also a paradigm-changing potential and
is likely to lead to new discoveries in the field. The planned experiments will help us to better characterize the
pericyte reservoirs in the CNS in order to design future therapies for reservoir clearance and HIV cure.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
                item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ patent.updateTime }}
Michal Toborek其他文献
Michal Toborek的其他文献
{{
              item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
{{ truncateString('Michal Toborek', 18)}}的其他基金
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
- 批准号:10432128 
- 财政年份:2021
- 资助金额:$ 48.36万 
- 项目类别:
Defining brain pericytes as a novel and myeloid-derived HIV reservoir
将大脑周细胞定义为一种新型的、源自骨髓的 HIV 储存库
- 批准号:10612454 
- 财政年份:2021
- 资助金额:$ 48.36万 
- 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:10645136 
- 财政年份:2020
- 资助金额:$ 48.36万 
- 项目类别:
Novel role of inflammasome activation in ART neurotoxicity
炎症小体激活在 ART 神经毒性中的新作用
- 批准号:10163270 
- 财政年份:2020
- 资助金额:$ 48.36万 
- 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:10371747 
- 财政年份:2020
- 资助金额:$ 48.36万 
- 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:10622305 
- 财政年份:2020
- 资助金额:$ 48.36万 
- 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:10404960 
- 财政年份:2020
- 资助金额:$ 48.36万 
- 项目类别:
Novel role of inflammasome activation in ART neurotoxicity
炎症小体激活在 ART 神经毒性中的新作用
- 批准号:9925422 
- 财政年份:2020
- 资助金额:$ 48.36万 
- 项目类别:
Targeting Inflammasomes in Substance Abuse and HIV
针对药物滥用和艾滋病毒中的炎症小体
- 批准号:10208845 
- 财政年份:2020
- 资助金额:$ 48.36万 
- 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:MR/X02329X/1 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Fellowship 
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:MR/Y009568/1 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Fellowship 
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:10090332 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Collaborative R&D 
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:MR/X021882/1 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Research Grant 
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:MR/X029557/1 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Research Grant 
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:EP/Y003527/1 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Research Grant 
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:EP/Y030338/1 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Research Grant 
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:2312694 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Standard Grant 
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:24K19395 
- 财政年份:2024
- 资助金额:$ 48.36万 
- 项目类别:Grant-in-Aid for Early-Career Scientists 
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:2244994 
- 财政年份:2023
- 资助金额:$ 48.36万 
- 项目类别:Standard Grant 

 刷新
              刷新
            
















 {{item.name}}会员
              {{item.name}}会员
            



